Tag: MedMen
-
Marijuana Update: Ravenquest (RQB.V), CROP (CROP.C), Lifestyle Delivery Systems (LDS.C), iAnthus (IAN.C), and trust
The ability to trust the people you put your money into is of utmost importance. ‘Management’ is oft cited as one of the pillars of a company’s success, but management in this instance could also be defined as ‘trust’. If I asked to borrow money from you in the street, your ability to trust me…
-
MedMen (MMEN.C) execs get real fricken nasty (again)
If you owned a 5% share in a 300-foot yacht, and the captain refused to let you sell your interest – then ran the ship aground – you’d have an idea how early MedMen (MMEN.C) investors, Brent Cox and Omar Mangalji feel. Collectively, Cox and Mangalji own about 19 million shares of MedMen – a…
-
Shell Game: How Wayland Group (WAYL.C) built a paper empire and the loan that may drag it under
PROLOGUE: Cannabis companies, as we know them in our minds, rarely exist. Oh sure, some have buildings and staff, some grow things and others might even have a license. But even those with big buildouts and massive market caps are, for the most part, a promise of what’s to come, maybe, some time, kinda. But…
-
MedMen (MMEN.C) Q3, 2019 revenues and a devastating Rolling Stone article
It’s true: we do enjoy kicking MedMen (MMEN.C) around. Why do we dislike this grotesquely unprofitable company so intensely? Because Adam Bierman (CEO) and Andrew Modlin (President) are greedy. Not – “I-fly-1st-class-and-pay-my-workers-minimum-wage” greedy. Not – “I-cheat-on-my-taxes” greedy. Not – “I’m-unloading-cheap-paper-through-a-numbered-company” greedy. Crazy, almost psychopathically greedy. We dislike them for the same reason we dislike Namaste’s…
-
Cannara Biotech (LOVE.C) makes MedMen look like a charitable institution
Cannara Biotech (LOVE.C) is a pig. I mean, okay. Pigs are actually kind of cool, they’re smart and bacon tastes good and they like a tummy rub, so Cannara is not actually a pig. But it is a trap for your money, and you should ideally not play with money traps because their sole purpose is,…
-
Gamechanger: iAnthus (IAN.C) and MPX Bioceutical (MPX.C) to merge, go after MedMen (MMEN.C)
A week ago, US dispensary roll-up play MedMen (MMEN.C) closed an $86m financing and a $99.95m loan to help them complete a $682m deal to buy PharmaCann, which has ten dispensaries and three weed grows. It was big news and propelled MMEN stock, which many deem to be overpriced before the deal, substantially higher still.…
-
MedMen (MMEN.C) blows out stock to buy 10 dispensaries, three weed farms in Pharmacann deal
In news that pushed MedMen’s (MMEN.C) share price to new highs, the red shirt crew have announced they’re buying US based Pharmacann LLC for $682 million… or, rather, $682 million of MMEN stock, as of October 9. Mind you, the news drove the company share price up significantly, meaning the actual price now being paid…
-
MedMen (MMEN.C) legal demands clearer: Half a billion dollars from EquityGuhahahahaha
The Streisand Effect is what happens when a person or company sends out legal threats to stop people from seeing something and, in turn, makes that thing they didn’t want seen go viral. MedMen’s lawyers probably should have talked to their clients about this before they started sending us weird legal demands because wow, you…
-
MedMen (MMEN.C) employees outraged at dispensary tipping clawback.
Equity Guru has been approached by several employees of MedMen’s (MMEN.C) California dispensaries who are telling us colleagues are walking out, upset about a new and unexplained pay cheque deduction that hit this week. MedMen, a CSE-listed US cannabis dispensary chain, built around high-end retail outlets geared towards urban professionals, boasts that its stores are…